Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11987558 ALK5 inhibitors and their uses
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 22 May, 2024
"Created via: Patent importer"
Golden AI
created this topic on 22 May, 2024
Edits made to:
Infobox
(
+17
properties)
Article
(
+80
characters)
US Patent 11987558 ALK5 inhibitors and their uses
Article
Patent abstract
The present disclosure relates to ALK5 inhibitors and their uses.
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11987558
0
Patent Inventor Names
Dori A. Thomas-Karyat
0
Date of Patent
May 21, 2024
0
Patent Application Number
18189387
0
Date Filed
March 24, 2023
0
Patent Citations
US Patent 7189733 Compositions and methods for inhibiting TGF-β
0
US Patent 7557130 Bicyclic heteroaromatic alanines
0
US Patent 7678810 Thiazole derivative
0
US Patent 8080568 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors
0
US Patent 8268857 Compositions and methods for inhibiting TGF-β
0
US Patent 8871744 Compounds and methods for selectively targeting tumor-associated mucins
0
US Patent 8900589 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
0
US Patent 9073918 Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5
0
US Patent 11583593 Antibody-ALK5 inhibitor conjugates and their uses
0
Patent Primary Examiner
Phuong Huynh
0
Find more entities like US Patent 11987558 ALK5 inhibitors and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE